Compare ETFs
Up to five funds side by side: fees, size, yields, performance, risk, top holdings and sector mix, with a normalized total-return chart.
| Metric |  THNR Amplify Weight Loss Drug &… |
|---|---|
| Price | 24.54 +1.17% |
| Issuer | Amplify |
| AUM | $5.6M |
| Expense Ratio | 0.59% |
| Yield (TTM) | 1.68% |
| Inception | May 21, 2024 |
| Holdings | 20 |
| Avg Volume | 1.78K |
| YTD | -2.78% |
| 1Y total | +2.17% |
| 3Y total (ann.) | — |
| 5Y total (ann.) | — |
| Volatility 1Y | 18.92% |
| Sharpe 1Y | 0.121 |
| Max drawdown 1Y | -13.11% |
| Beta vs S&P 500 (3Y) | 0.63 |
| Top 10 holdings | LLY 10.53% NVO 8.81% AMGN 5.81% ABBV 5.64% PFE 5.47% GILD 5.43% ROP.SW 5.41% 1093.HK 5.39% AZN 5.34% MRK 5.24% |
| Sector mix | Healthcare 99.65% Financial Services 1.08% |
Total Return, normalized
Dividend-adjusted daily closes over the last 12 months, normalized to 0% at the range start.
Market data delayed approximately 15–20 minutes unless otherwise indicated. Comparison presents measurable characteristics only; it is not advice about which fund suits anyone.